Your search returned 143 studies. (Get alerts for new studies):
- Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections - Hepatitis C
1 Location available
- Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Conditions: Hepatitis C
1 Location available
- High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
Conditions: Chronic Hepatitis C
1 Location available
- Brief Intervention for Drug Misuse in the Emergency Department
Conditions: Substance Abuse Detection - Acquired Immunodeficiency Syndrome - Hepatitis B - Hepatitis C - Brief Intervention - HIV Infections
1 Location available
- An Observational Study on Long-Term Persistence of Resistant Mutations And Durability of Sustained Virological Response in Patients With Chronic Hepat
Conditions: Hepatitis C, Chronic
6 Locations available
- Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Conditions: Hepatitis D
2 Locations available
- Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease
Conditions: Cirrhosis - End Stage Liver Disease - Hepatitis C
1 Location available
- A Rapid 10-minute Liver MRI
Conditions: Underlying Liver Disease - Hepatitis - Fibrosis of Liver - Cirrhosis With Suspicion of Liver Cancer - Lesion on a Prior Ultrasound, CT or Outside MRI
1 Location available
- Increasing Viral Testing in the Emergency Department
Conditions: Drug Use - HIV - Hepatitis C
1 Location available
- Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HI
Conditions: HIV Infections - Hepatitis C
1 Location available
- Open-Label Hepatic Impairment Study
Conditions: Hepatitis C
1 Location available
- Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
Conditions: Chronic Hepatitis B e Antigen Positive - Chronic Hepatitis B e Antigen Negative
1 Location available
- Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Conditions: Hepatitis C - Liver Transplant Recipient
1 Location available
- Racial Difference in HCV/Host Interactions
Conditions: Hepatitis C
3 Locations available
- HIV-HCV Coinfection: Impact of Immune Dysfunction
Conditions: HIV Infections - Hepatitis
1 Location available
- Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis - Nonalcoholic Fatty Liver Disease
1 Location available
- An Integrated Care Model for Improving HCV Patient Outcomes IIR-07-101-3
Conditions: Hepatitis C
1 Location available
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocelluar Carcinoma
Conditions: Liver Cancer - Hepatitis B - Hepatitis C - Hepatobiliary Cancers Liver - Hepatobiliary Cancers
1 Location available
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Conditions: Nonalcoholic Steatohepatitis
1 Location available
- Safety, Metabolism, and Antioxidant Activity of Silymarin and Green Tea Extract in Patients With Chronic Hepatitis C
Conditions: Chronic Hepatitis C - Oxidative Stress
1 Location available
- Concentration-Controlled Ribavirin for the Treatment of Patients With Chronic Hepatitis C Virus Infection
Conditions: Hepatitis C Virus
1 Location available
- The Effect of Human Immunodeficiency Virus (HIV) Tat Protein on Hepatitis C Virus (HCV) Replication in an In-vitro Model System
Conditions: Human Immunodeficiency Virus (HIV) - Hepatitis C, Chronic
1 Location available
- Hepatitis B Research Network Pediatric Cohort Study (HBRN)
Conditions: Hepatitis B
5 Locations available
- Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
Conditions: HIV Infection - Hepatitis C
1 Location available
- Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
Conditions: Non Alcoholic Fatty Liver Diseases (NAFLD)
1 Location available
- The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV - Hepatitis C - HIV and Hepatitis C Coinfection
1 Location available
- TMC435HPC3002 - 3-Year Follow up of Patients After Administration of TMC435 for the Treatment of Chronic Hepatitis C.
Conditions: Hepatitis C
3 Locations available
- GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC
Conditions: Chronic Hepatitis C
26 Locations available
- GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection
Conditions: Hepatitis C, Chronic
24 Locations available
- Directly Observed Hepatitis C Treatment in Methadone Clinics
Conditions: Hepatitis C - Medication Adherence
1 Location available
- Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
Conditions: Hepatitis - HIV/AIDS
4 Locations available
- An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
1 Location available
- Comparison of Plasma & SMARTplasma for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) Antibody Testing
Conditions: Human Immunodeficiency Virus Infection - Hepatitis C
5 Locations available
- Gilead Sustained Virologic Response (SVR) Registry
Conditions: Hepatitis C, Chronic
36 Locations available
- Telaprevir in Combination With Peginterferon and Ribavirin in Treatment-experienced Black/African American Subjects.
Conditions: Hepatitis C
15 Locations available
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B
Conditions: Hepatitis B - HBV
1 Location available
- A Study to Compare the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) to Standard of Care in Subjects
Conditions: Chronic Hepatitis C Virus
11 Locations available
- Transplant Patient Registry of Liver, Kidney and/or Pancreas
Conditions: Hepatitis B - Hepatitis C - Liver Cirrhosis - Hepatocellular Carcinoma - Polycystic Kidney Diseases
1 Location available
- Effective Treatment of Hepatitis C in Substance Users
Conditions: Hepatitis C - Opiate Dependence
1 Location available
- Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
Conditions: HIV - Hepatitis C - Infections
4 Locations available
- A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area
Conditions: Carcinoma, Hepatocellular - Liver Cirrhosis, Alcoholic - Hepatitis, Alcoholic - Hepatitis, Chronic - Hepatitis, Viral, Human
3 Locations available
- Study of SCY-635, Pegasys and Copegus in Hepatitis C
Conditions: Hepatitis C Infection
3 Locations available
- Observational Study of Persons With Hepatitis B Virus Infection in North America
Conditions: Chronic Hepatitis B e Antigen Positive - Chronic Hepatitis B e Antigen Negative
1 Location available
- Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Conditions: Hepatitis C
4 Locations available
- A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
2 Locations available
- TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis
Conditions: Hepatitis C
20 Locations available
- Assessing Single and Multiple Doses of HCV NS5A Inhibitor IDX719 in Healthy and HCV-Infected Subjects
Conditions: Hepatitis C, Chronic
1 Location available
- An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Conditions: Hepatitis C
5 Locations available
- Three-year Follow-up Study of Subjects Who Participated in a Previous BMS-914143 Chronic Hepatitis C Clinical Trial
Conditions: Hepatitis C
8 Locations available
- Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
Conditions: Post Liver Transplantation Weight Gain - Post Liver Transplantation Obesity - Nonalcoholic Steatohepatitis
1 Location available
- Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV)
Conditions: Hepatitis C
1 Location available
- Baclofen to Reduce Alcohol Use in Veterans With HCV
Conditions: Hepatitis C - Alcohol Use Disorders
3 Locations available
- Cell Bound Complement Activation Proteins as Markers of Liver Injury
Conditions: Hepatitis C
1 Location available
- A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic HBV-Infection
Conditions: Chronic Hepatitis B Virus, Pediatric
16 Locations available
- The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)
Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) - Nonalcoholic Steatohepatitis (NASH)
9 Locations available
- Vitamin D Deficiency in Subjects With Chronic Hepatitis C Compared to Healthy Volunteers
Conditions: Chronic Hepatitis C
1 Location available
- Association Between Hepatitis C Infection and Renal Cell Carcinoma
Conditions: Hepatitis C - Renal Cell Carcinoma - Colorectal Cancer
1 Location available
- Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (SCH503034-P07614 AM4)
Conditions: Hepatitis C, Chronic
2 Locations available
- Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
Conditions: HIV Infection - Hepatitis C
1 Location available
- A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Conditions: Hepatitis C, Chronic
36 Locations available
- A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy Subjects
Conditions: Chronic Hepatitis C
2 Locations available
- An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recur
Conditions: Hepatitis C - Hepatocellular Carcinoma
1 Location available
- Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation
Conditions: Hepatitis C, Chronic - Non-Alcoholic Fatty Liver Disease
1 Location available
- Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection
Conditions: Hepatitis C
1 Location available
- Leukapheresis for Research on HCV-Coinfected Patients
Conditions: Hepatitis C - HIV Infections
4 Locations available
- Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Admini
Conditions: HIV Infections - Hepatitis B Virus
1 Location available
- A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Conditions: Hepatitis B, Chronic
8 Locations available
- Psychoeducation for Hepatitis and Alcohol Behaviors
Conditions: Hepatitis C - Substance Abuse
1 Location available
- A Study of Vaniprevir (MK-7009) in Patients With Chronic Hepatitis C Infection After Participation in Other Vaniprevir Studies (MK-7009-028 AM4)
Conditions: Hepatitis C, Chronic
2 Locations available
- Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen
Conditions: Hepatitis B Virus
9 Locations available
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound
Conditions: Normal - Alcoholism - Cirrhosis - Hepatitis C
1 Location available
- Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients
Conditions: Chronic Hepatitis B
5 Locations available
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Conditions: Patients Undergoing Routine Health Care - Heart Diseases - Inflammatory Bowel Diseases - Autoimmune Disease - Inflammatory Diseases - Blood Coagulation Disorders - Hepatitis C - Non-Metastatic Neoplasm
1 Location available
- Adolescents' Response to Hepatitis B Vaccine Booster Dose
Conditions: Hepatitis B
2 Locations available
- BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Conditions: Hepatitis C
34 Locations available
- Staged Phase I/II Hepatitis C Prophylactic Vaccine
Conditions: Hepatitis C
1 Location available
- Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Conditions: Hepatitis C, Chronic
4 Locations available
- Optimizing Serologic Tests for Diagnosis of HSV-2 Infection in Veterans With HCV, Phase I; 3 Grams Daily Valacyclovir in Chronic Hepatitis C Infection
Conditions: Chronic Hepatitis C Infection
1 Location available
- Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not P
Conditions: Chronic Hepatitis C
7 Locations available
- Polyunsaturated Fatty Acids (PUFA) in the Treatment of Non-Alcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Mellitus (PUFA)
Conditions: Fatty Liver
2 Locations available
- Risk Assessment of Long-Haul Truck Drivers
Conditions: Gonorrhea - Chlamydia Infections - Hepatitis B - Hepatitis C - Diabetes Mellitus - Hypertension - Obesity - HIV Infections - Hyperlipidemia
1 Location available
- Hepatitis C Treatment and Atherosclerosis
Conditions: Chronic Hepatitis C - Atherosclerosis
1 Location available
- Increasing Hepatitis B Screening Among Korean Church Attendees
Conditions: Hepatitis B
1 Location available
- Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients
Conditions: Obesity - Insulin Resistance - Metabolic Syndrome - Hepatitis C
1 Location available
- Open Label Study to Evaluate the Safety, Efficacy, Viral Kinetics, Genetic, Epigenetic, and Proteomic Expression of Weekly Peginterferon Alpha 2a and
Conditions: Hepatitis C - HIV
1 Location available
- A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Con
Conditions: Hepatitis C
3 Locations available
- HCV/HIV Coinfection: Antiviral Therapy and Fibrosis
Conditions: HIV Infection - Hepatitis C
1 Location available
- Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/HCV Negative Volunteers
Conditions: Hepatitis C - HIV
1 Location available
- A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1
Conditions: Hepatitis C Virus Infection
2 Locations available
- Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and
Conditions: Hepatitis C, Chronic
59 Locations available
- Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
Conditions: Hepatitis C Infection
1 Location available
- Safety and Efficacy Study of BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Untreated Hepatitis C Patients Coinfected With HIV Virus
Conditions: Hepatitis C, Genotype 1
20 Locations available
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Cli
Conditions: Hepatitis C
10 Locations available
- Lonafarnib for Chronic Hepatitis D
Conditions: Hepatitis D
1 Location available
- 3 Grams Daily Valacyclovir in Chronic Hepatitis C Infection (Phase II)
Conditions: Chronic Hepatitis C Infection
1 Location available
- A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection
Conditions: Hepatitis B
1 Location available
- Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis, - Hemochromatosis - Hepatitis - Hepatolenticular Degeneration - Liver Disease
1 Location available
- Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection
Conditions: HIV Infections - Hepatitis C
1 Location available
- Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
Conditions: HIV Infections - Hepatitis C Virus
2 Locations available
- Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein Profiling
Conditions: Hepatitis C
1 Location available
- Hepatitis B Research Network Adult Cohort Study
Conditions: Hepatitis B
20 Locations available
- Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir
Conditions: Chronic Hepatitis B
28 Locations available
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B
Conditions: Hepatitis B
11 Locations available
- Behavioral Science Aspects of Rapid Test Acceptance
Conditions: HIV - Hepatitis C - Hepatitis B - Syphilis
1 Location available
- A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Pa
Conditions: Hepatitis C
65 Locations available
- Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501
Conditions: Thrombocytopenia
1 Location available
- Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previousl
Conditions: Chronic Hepatitis C
17 Locations available
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin for 12 Weeks
Conditions: Hepatitis C, Chronic
14 Locations available
- Phase III Trial of BI 201335 in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)- Human Immunodeficiency Virus (HIV) Coinfected Patients
Conditions: Hepatitis C, Chronic
26 Locations available
- Peginterferon and Ribavirin, With or Without Telaprevir, for Genotype 1 Hepatitis C and IL28B CC Polymorphism
Conditions: Hepatitis C
2 Locations available
- Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Conditions: Hepatitis C Virus
8 Locations available
- GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV)
Conditions: Chronic Genotype 1a or 1b HCV Infection
23 Locations available
- A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-267 and With and Without Ribavirin (RBV) in Treatment-Naïve Subjec
Conditions: Hepatitis C Virus
3 Locations available
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C
Conditions: Hepatitis C
10 Locations available
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant
Conditions: Hepatitis C Virus - Liver Transplant Recipient - Recurrent Fibrosis
1 Location available
- Ribavirin Pregnancy Registry
Conditions: Birth Defects - Pregnancy Complications - Hepatitis C
1 Location available
- Hepatitis C Virus and the Humoral Immune System
Conditions: Hepatitis C Virus
1 Location available
- The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy - Hepatitis C - Liver Cirrhosis
1 Location available
- Development of Biomarker for Development of Non-Alcoholic Steatohepatitis (NASH) in Children
Conditions: Non-Alcoholic Steatohepatitis
1 Location available
- Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
1 Location available
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roc
Conditions: Hepatitis C, Chronic
1 Location available
- Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
Conditions: Hepatitis C Virus
1 Location available
- Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients
Conditions: Hepatitis B
1 Location available
- Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment
Conditions: Hepatitis C
1 Location available
- Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Conditions: Hepatitis C, Chronic
6 Locations available
- Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections - Hepatitis - Sexually Transmitted Infections
3 Locations available
- Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
Conditions: Hepatitis C Infection - Thrombocytopenia
1 Location available
- Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
Conditions: Steatohepatitis
33 Locations available
- Duration of Long-term Immunity After Hepatitis B Virus Immunization
Conditions: Hepatitis B
1 Location available
- Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
Conditions: Hepatitis C Patients
1 Location available
- Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin
Conditions: Hepatitis C
11 Locations available
- A Study Of Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B
Conditions: HIV Coinfection - Hepatitis C - Hepatitis B - Hepatotoxicity
15 Locations available
- An Observational Study on The Prediction of Adverse Events in Patients With Chronic Hepatitis C Receiving a Long-Acting Interferon Plus Ribavirin (GUA
Conditions: Hepatitis C, Chronic
1 Location available
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis - HIV - Liver Cancer
3 Locations available
- Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy
Conditions: Chronic Hepatitis C - Genotype 1
5 Locations available
- Safety Study of INX-08189, Pharmacokinetic and Pharmacodynamic With Ribavirin and Food Effect Study, in Chronically-infected Genotype 1 Hepatitis C Vi
Conditions: Hepatitis C
1 Location available
- A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Conditions: Hepatitis C
22 Locations available
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Conditions: Hepatitis C
2 Locations available
- A Study of Mericitabine in Combination With Telaprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C
Conditions: Hepatitis C, Chronic
1 Location available
- Study Comparing BMS-790052 (Daclatasvir) to Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Untreated Hepatitis C Patients
Conditions: Hepatitis C
12 Locations available
- Entecavir and Peginterferon for Immune-Tolerant Adults With Chronic Hepatitis B
Conditions: Hepatitis B - Chronic Hepatitis B e Antigen Positive
1 Location available
- Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Conditions: Non Alcoholic Fatty Liver Disease - Steatohepatitis - Hypertriglyceridemia - Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1
1 Location available
- Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy While on the Orthotopic Liver Transplant (OLT) List
Conditions: Hepatitis B
2 Locations available
|